We are live on
!
Find out more
ED
Exane Derivatives Portfolio holdings
AUM
$174M
1-Year Est. Return
7.84%
This Fund
S&P 500
This Quarter
Est. Return
+7.68%
1 Year Est. Return
-7.84%
3 Year Est. Return
+42.72%
5 Year Est. Return
+56.28%
10 Year Est. Return
–
AUM
$413M
AUM Growth
-$3.2M
(-0.77%)
Cap. Flow
-$7.27M
Cap. Flow
% of AUM
-1.76%
Top 10 Holdings %
Top 10 Hldgs %
30.14%
Holding
1,129
New
83
Increased
245
Reduced
309
Closed
247
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ferrari
RACE
|
+$21.4M |
| 2 |
Stellantis
STLA
|
+$18M |
| 3 |
CNH
CNH Industrial
CNH
|
+$11.6M |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$7.3M |
| 5 |
iShares S&P 500 Value ETF
IVE
|
+$6.71M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UBS Group
UBS
|
+$23.5M |
| 2 |
Linde
LIN
|
+$8.45M |
| 3 |
Visa
V
|
+$5.42M |
| 4 |
Alcon
ALC
|
+$3.14M |
| 5 |
T-Mobile US
TMUS
|
+$3.04M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 19.6% |
| 2 | Technology | 15.31% |
| 3 | Miscellaneous | 15.03% |
| 4 | Industrials | 9.82% |
| 5 | Financials | 7.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
351
BioMarin Pharmaceuticals
BMRN
$12.5B
| $186K | 0.05% |
2,109
-667
| -24% | -$55K |
|
352
ProShares Ultra S&P500
SSO
$8.82B
| $186K | 0.05% |
5,080
| – | – |
|
353
State Street Industrial Select Sector SPDR ETF
XLI
$30.9B
| $184K | 0.04% |
+1,737
| New | +$180K |
|
354
Agree Realty
ADC
$8.67B
| $184K | 0.04% |
2,572
+2,463
| +2,260% | +$171K |
|
355
Kilroy Realty
KRC
$4.02B
| $183K | 0.04% |
2,748
+266
| +11% | +$18.2K |
|
|
DOO
356
Bombardier Recreational Products
DOO
$4.26B
| $182K | 0.04% |
2,076
-614
| -23% | -$53.3K |
|
357
Incyte
INCY
$24.9B
| $179K | 0.04% |
2,441
+717
| +42% | +$48.3K |
|
358
Acushnet Holdings
GOLF
$4.85B
| $175K | 0.04% |
3,300
-975
| -23% | -$51.2K |
|
359
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$15.2B
| $174K | 0.04% |
1,996
| – | – |
|
360
Arista Networks
ANET
$251B
| $172K | 0.04% |
+4,796
| New | +$143K |
|
|
MTTR
361
DELISTED
Matterport, Inc. Class A Common Stock
MTTR
| $172K | 0.04% |
+8,327
| New | +$191K |
|
362
Aurinia Pharmaceuticals
AUPH
$2.19B
| $172K | 0.04% |
7,501
-6,828
| -48% | -$162K |
|
363
Home Depot
HD
$307B
| $171K | 0.04% |
413
-1,240
| -75% | -$472K |
|
364
Lumentum
LITE
$80.8B
| $170K | 0.04% |
1,607
-230
| -13% | -$20.9K |
|
365
Deckers Outdoor
DECK
$10.8B
| $168K | 0.04% |
2,748
-852
| -24% | -$54.9K |
|
366
Invesco Dorsey Wright Healthcare Momentum ETF
PTH
$286M
| $168K | 0.04% |
3,246
-2,436
| -43% | -$127K |
|
367
Root
ROOT
$813M
| $166K | 0.04% |
+2,974
| New | +$233K |
|
368
Beyond Meat
BYND
$180M
| $166K | 0.04% |
85
-15
| -15% | -$38.3K |
|
369
Palantir
PLTR
$414B
| $165K | 0.04% |
9,086
+4,959
| +120% | +$110K |
|
370
Invesco MSCI Sustainable Future ETF
ERTH
$127M
| $164K | 0.04% |
2,459
| – | – |
|
371
Bloom Energy
BE
$79.4B
| $163K | 0.04% |
7,448
-2,134
| -22% | -$54K |
|
372
Madrigal Pharmaceuticals
MDGL
$12.1B
| $162K | 0.04% |
1,916
| – | – |
|
373
Keysight
KEYS
$54.4B
| $160K | 0.04% |
+777
| New | +$145K |
|
374
Canadian Natural Resources
CNQ
$103B
| $160K | 0.04% |
+7,749
| New | +$157K |
|
375
Spotify
SPOT
$114B
| $159K | 0.04% |
681
-558
| -45% | -$140K |
|
Similar funds
PC
TWMP
LPWM
ACM
HWIS
LWM
EW
GDWAM
Exane Derivatives's Q4 2021 Portfolio in Review
As of Q4 2021, Exane Derivatives held 1,129 positions worth $413M, down 0.77% from $417M the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Exane Derivatives's Q4 2021 filing shows 83 new, 245 increased, 309 reduced and 247 closed positions. Its largest new stake was EngageSmart, Inc.: 45,605 shares worth $1.1M. The largest sale was UBS Group, an estimated $23.5M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 20% of assets, up from 11% a quarter earlier, followed by Technology and Miscellaneous.
- Exane Derivatives's largest Q4 2021 buy was EngageSmart, Inc.: 45,605 shares worth $1.1M.
- Exane Derivatives added most to Ferrari in Q4 2021, an estimated $21.4M increase.
- Exane Derivatives's biggest Q4 2021 reduction was UBS Group, cutting an estimated $23.5M.
- Exane Derivatives fully exited Visa in Q4 2021, selling an estimated $5.42M.
- Exane Derivatives's ten largest holdings make up 30% of its $413M portfolio in Q4 2021.
- Exane Derivatives opened 83 new positions and closed 247 in Q4 2021.
- Exane Derivatives's portfolio value fell 0.77% quarter-over-quarter to $413M.
Based on Exane Derivatives's 13F filing for Q4 2021, filed 28 Jan 2022.